Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection

Liver Transplantation and Surgery

Volumn 5, Issue 4, 1999, Pages 294-300

  Delladetsima, J K ^a   Boletis, J N ^a   Makris, F ^a   Psichogiou, M ^a   Kostakis, A ^a   Hatzakis, A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CYCLOSPORIN A; GAMMA GLUTAMYLTRANSFERASE; METHYLPREDNISOLONE; VIRUS RNA; ZIDOVUDINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CASE REPORT; CHOLESTATIC HEPATITIS; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GRAFT REJECTION; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER DYSFUNCTION; LIVER FAILURE; MALE; PRIORITY JOURNAL; SEPSIS; SEROCONVERSION; SEROLOGY; TREATMENT OUTCOME;

EID: 0033033402     PISSN: 10743022     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500050417     Document Type: Article

References (22)

1. 1 Davies SE, Portmann BC, O'Grady JG, Aldis PM, Chaggar K, Alexander GJM, Williams R. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991 ; 13: 150–157. MEDLINE
2. 2 Benner KG, Lee RG, Keeffe EB, Lopez RR, Sasaki AW, Wright Pinson C. Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology 1992 ; 103: 1307–1312. MEDLINE
3. 3 Harrison RF, Davies MH, Goldin RD, Hubscher SG. Recurrent hepatitis B in liver allografts: A distinctive form of rapidly developing cirrhosis. Histopathology 1993 ; 23: 21–28. MEDLINE
4. 4 Walker N, Apel R, Kerlin P, Horn M, Tinniswood R, Lynch S, et al. Hepatitis B virus infection in liver allografts. Am J Surg Pathol 1993 ; 17: 666–677. MEDLINE
5. 5 Chen CH, Chen PJ, Chu JS, Yeh KH, Lai MY, Chen DS. Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation. Gastroenterology 1994 ; 107: 1514–1518. MEDLINE
6. 6 Booth JC, Goldin RD, Brown JL, Karayiannis P, Thomas HC. Fibrosing cholestatic hepatitis in a renal transplant recipient associated with the hepatitis B virus precore mutant. J Hepatol 1995 ; 22: 500–503. MEDLINE
7. 7 Lam PWY, Wachs ME, Somberg KA, Vincenti F, Lake JR, Ferell LD. Fibrosing cholestatic hepatitis in renal transplant recipients. Transplantation 1996 ; 61: 378–381. MEDLINE
8. 8 Fang JWS, Wright TL, Lau JYN. Fibrosing cholestatic hepatitis in patient with HIV and hepatitis B. Lancet 1993 ; 342: 1175. MEDLINE
9. 9 McIvor C, Morton J, Bryant A, Cooksley WG, Durrant S, Walker N. Fatal reactivation of precore mutant hepatitis B virus associated with fibrosing cholestatic hepatitis after bone marrow transplantation. Ann Intern Med 1994 ; 121: 274–275. MEDLINE
10. 10 Cooksley WG, McIvor CA. Fibrosing cholestatic hepatitis and HBV after bone marrow transplantation. Biomed Pharmacother 1995 ; 49: 117–124. MEDLINE
11. 11 Dickson RC, Caldwell SH, Ishitani MB, Lau JY, Driscoll CJ, Stevenson WC, et al. Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation. Transplantation 1996 ; 61: 701–705. MEDLINE
12. 12 Lim HL, Lau GKK, Davis GL, Dolson DF, Lau JYN. Cholestatic hepatitis leading to hepatic failure in a patient with organ‐transmitted hepatitis C virus infection. Gastroenterology 1994 ; 106: 248–251. MEDLINE
13. 13 Zylberberg H, Carnot F, Mamzer MF, Blancho G, Legendre C, Pol S. Hepatitis C virus–related fibrosing cholestatic hepatitis after renal transplantation. Transplantation 1997 ; 63: 158–160. MEDLINE
14. 14 Lau JYN, Bain VG, Davies SE, O'Grady JG, Alberti A, Alexander GJM, Williams R. High‐level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology 1992 ; 102: 956–962. MEDLINE
15. 15 Mason AL, Wick M, White HM, Benner KG, Lee RG, Regenstein F, et al. Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitis. Gastroenterology 1993 ; 105: 237–244. MEDLINE
16. 16 Chisari FV, Filippi P, Buras J, McLachlan A, Popper H, Pinkert CA, et al. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in trangenic mice. Proc Natl Acad Sci U S A 1987 ; 84: 6909–6913. MEDLINE
17. 17 Roingeard P, Romet‐Lemonne JL, Leturcq D, Goudeau A, Essex M. Hepatitis B virus core antigen (HBcAg) accumulation in an HBV nonproducer clone of HepG2‐transfected cells is associated with cytopathic effect. Virology 1990 ; 179: 113–120. MEDLINE
18. 18 Angus PW, Locarnini SA, McCaughan GW, Jones RM, McMillan JS, Bowden DS. Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation. Hepatology 1995 ; 21: 14–18. MEDLINE
19. 19 Hawkins AE, Gilson RJ, Gilbert N, Wreghitt TG, Gray JJ, Ahlers de Boer I, et al. Hepatitis B virus surface mutations associated with infection after liver transplantation. J Hepatol 1996 ; 24: 8–14. MEDLINE
20. 20 Trautwein C, Schrem H, Tillmann HL, Kubicka S, Walker D, Boker KH, et al. Hepatitis B virus mutations in the pre‐S genome before and after liver transplantation. Hepatology 1996 ; 24: 482–488. MEDLINE
21. 21 Jamal H, Regenstein F, Farr G, Perrillo RP. Prolonged survival in fibrosing cholestatic hepatitis with long‐term ganciclovir therapy. Am J Gastrointerol 1996 ; 91: 1027–1030.
22. 22 Al Faraidy K, Yoshida EM, Davis JE, Vartanian RK, Anderson FH, Steinbrecher UP. Alteration of the dismal history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine. Transplantation 1997 ; 64: 926–928. MEDLINE